Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
8.00
-0.07 (-0.87%)
At close: Aug 1, 2025, 4:00 PM
7.90
-0.10 (-1.25%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Company Description

Prenetics Global Limited, a consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally.

The company operates in three segments: Prevention, Diagnostics, and Consumer Health. It operates IM8 Health that sells health and wellness products; and provides fulfillment and distribution services for sports nutrition products under the Consumer Health segment.

The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions under Prevention segment.; and ACT Genomics that provides precision oncology testing services under the Diagnostics segment.

In addition, it develops and commercializes multi-cancer early detection technologies. Further, the company offers a range of genomic profiling panels tailored for requirements and clinician needs.

Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Prenetics Global Limited
Prenetics Global logo
CountryHong Kong
Founded2014
IndustryDiagnostics & Research
SectorHealthcare
Employees285
CEOSheng Wu Yeung

Contact Details

Address:
Unit 703-706, K11 Atelier King’s Road, 728 King’s Road
Quarry Bay
Hong Kong
Phone852 2210 9588
Websiteprenetics.com

Stock Details

Ticker SymbolPRE
ExchangeNASDAQ
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001876431
CUSIP NumberG72245106
ISIN NumberKYG722451229
SIC Code3826

Key Executives

NamePosition
Samantha KwokChief of Staff to Group Chief Executive Officer and Vice President of People & Operations
Sheng Wu YeungCo-Founder, Chairperson and Chief Executive Officer
Dr. Chi Hung Tzang Ph.D.Co-Founder and Chief Scientific Officer
Hoi Chun LoChief Financial Officer
Dr. Senthil Kumar Sundaram M.D.Chief Clinical Officer
Joel NeohChief Consumer Officer
David Eric VanderveenDirector and President of Americas
Dr. James DiNicolantonioChief Nutrition Officer, Member of Scientific and Medical Advisory Board

Latest SEC Filings

DateTypeTitle
Aug 1, 20256-KReport of foreign issuer
Jul 22, 2025F-3Filing
Jul 18, 202520-F/AFiling
Jul 18, 20256-KReport of foreign issuer
Jul 17, 20256-KReport of foreign issuer
Jun 18, 20256-KReport of foreign issuer
Jun 18, 20256-KReport of foreign issuer
Jun 16, 20256-KReport of foreign issuer
Jun 12, 20256-K/AFiling
Jun 12, 20256-KReport of foreign issuer